A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats
Pre‐clinical studies suggest that negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGluR5), including 2‐methyl‐6‐(phenylethynyl)pyridine (MPEP), 3‐[(2‐methyl‐1,3‐thiazol‐4‐yl)ethynyl]pyridine (MTEP) and fenobam are highly effective in attenuating drug‐taking an...
Saved in:
Published in | Addiction biology Vol. 19; no. 2; pp. 195 - 209 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.03.2014
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pre‐clinical studies suggest that negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGluR5), including 2‐methyl‐6‐(phenylethynyl)pyridine (MPEP), 3‐[(2‐methyl‐1,3‐thiazol‐4‐yl)ethynyl]pyridine (MTEP) and fenobam are highly effective in attenuating drug‐taking and drug‐seeking behaviors. However, both MPEP and MTEP have no translational potential for use in humans because of their off‐target effects and short half‐lives. Here, we report that 3‐fluoro‐5‐[(6‐methylpyridin‐2‐yl)ethynyl]benzonitrile (MFZ 10‐7), a novel mGluR5 NAM, is more potent and selective than MPEP, MTEP and fenobam in both in vitro binding and functional assays. Similar to MTEP, intraperitoneal administration of MFZ 10‐7 inhibited intravenous cocaine self‐administration, cocaine‐induced reinstatement of drug‐seeking behavior and cocaine‐associated cue‐induced cocaine‐seeking behavior in rats. Although MFZ 10‐7 and MTEP lowered the rate of oral sucrose self‐administration, they did not alter total sucrose intake. Further, MFZ 10‐7 appeared to be more potent than MTEP in inducing downward shifts in the cocaine dose–response curve, but less effective than MTEP in attenuating sucrose‐induced reinstatement of sucrose‐seeking behavior. MFZ 10‐7 and MTEP had no effect on basal locomotor behavior. These findings not only provide additional evidence supporting an important role for mGluR5 in cocaine reward and addiction, but also introduce a new tool for both in vitro and in vivo investigations with which to further characterize this role.
The mGluR5 negative allosteric modulators (NAMs) MPEP and MTEP are highly promising in treatment of addiction in experimental animals. However, their translational potential for use in humans is very low because of their off‐target effects and short half‐lives. Here, we report that MFZ 10‐7, a novel mGluR5 NAM, is more potent and selective than MPEP or MTEP in both in vitro binding and functional assays, and similarly effective as MTEP in attenuation of cocaine‐taking and cocaine‐seeking behavior in rats. |
---|---|
Bibliography: | an NIH Postdoctoral Intramural Research Training Award (IRTA) Fellowship istex:2B8DA66D39EAD5114BEBA95EEDE67B567A608272 ark:/67375/WNG-RSH1SBTN-K National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services ArticleID:ADB12086 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 1355-6215 1369-1600 |
DOI: | 10.1111/adb.12086 |